They showed that the culture’s tumour infiltrating lymphocytes (TILs) can preserve the original tumour-resident lymphocytes’ T-cell receptor repertoire and can be activated by checkpoint inhibitors (anti-PD1, anti-PDL1) to enhance anti-tumour cytotoxicity [18]. The gene discussed is CD274; the disease is neoplasm.